PMC9174998_01
Case presentation of case 1. CCRT, concurrent radiotherapy; CR, complete remission; CT, computed tomography; N, lymphonodus; PR, partial remission; PD, progression disease; RT, radiotherapy; T, tumor; TC, paclitaxel/carboplatin.
fonc-12-794153-g001.jpg
PMC9174998_01_fonc-12-794153-g001.jpg
f1
To date, the patient is in a stable condition with no severe adverse reactions and an overall survival (OS) time that has exceeded 21 months (Figure 1).
The timeline of diagnosis, interventions, and outcomes of case 1. SCC, squamous cell carcinoma; EGJ, esophagogastric junction; CT, computed tomography; cCCR, concurrent chemoradiotherapy.
fonc-12-794153-g002.jpg
PMC9174998_01_fonc-12-794153-g002.jpg
f2
The timeline of diagnosis, interventions and outcomes was summarized as  Figure 2 .
PMC9174998_02
Case presentation of case 2. CCRT, concurrent radiotherapy; CR, complete remission; CT, computed tomography; PR, partial remission; SD, stable disease; T, tumor; TC, paclitaxel/carboplatin; TP, paclitaxel/cis-platinum.
fonc-12-794153-g003.jpg
PMC9174998_02_fonc-12-794153-g003.jpg
f3
To date, the patient's condition has remained stable; the quality of life is good with an absence of severe adverse reactions, and OS time has exceeded 21 months (Figure 3).
The timeline of diagnosis, interventions, and outcomes of case 2. SCC, squamous cell carcinoma; EGJ, esophagogastric junction; CT, computed tomography.
fonc-12-794153-g004.jpg
PMC9174998_02_fonc-12-794153-g004.jpg
f4
The timeline of diagnosis, interventions and outcomes was summarized as  Figure 4 .